- Home
- MNTSW vs MRK Comparison
MNTSW vs MRK Comparison
Compare MNTSW & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTSW
- MRK
- Stock Information
- Founded
- MNTSW N/A
- MRK 2000
- Country
- MNTSW United States
- MRK United States
- Employees
- MNTSW 123
- MRK N/A
- Industry
- MNTSW Military/Government/Technical
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- MNTSW Industrials
- MRK Health Care
- Exchange
- MNTSW Nasdaq
- MRK Nasdaq
- Market Cap
- MNTSW N/A
- MRK 218.8B
- IPO Year
- MNTSW 2019
- MRK N/A
- Fundamental
- Price
- MNTSW $0.04
- MRK $84.61
- Analyst Decision
- MNTSW
- MRK Buy
- Analyst Count
- MNTSW 0
- MRK 15
- Target Price
- MNTSW N/A
- MRK $105.14
- AVG Volume (30 Days)
- MNTSW N/A
- MRK 13.0M
- Earning Date
- MNTSW N/A
- MRK 10-30-2025
- Dividend Yield
- MNTSW N/A
- MRK 3.82%
- EPS Growth
- MNTSW N/A
- MRK 20.41
- EPS
- MNTSW N/A
- MRK 6.49
- Revenue
- MNTSW N/A
- MRK $63,616,000,000.00
- Revenue This Year
- MNTSW N/A
- MRK $1.84
- Revenue Next Year
- MNTSW N/A
- MRK $5.24
- P/E Ratio
- MNTSW N/A
- MRK $13.07
- Revenue Growth
- MNTSW N/A
- MRK 1.82
- 52 Week Low
- MNTSW N/A
- MRK $73.31
- 52 Week High
- MNTSW N/A
- MRK $110.19
- Technical
- Relative Strength Index (RSI)
- MNTSW 57.11
- MRK 50.44
- Support Level
- MNTSW $0.04
- MRK $86.20
- Resistance Level
- MNTSW $0.07
- MRK $85.50
- Average True Range (ATR)
- MNTSW 0.01
- MRK 2.34
- MACD
- MNTSW 0.00
- MRK -0.25
- Stochastic Oscillator
- MNTSW 37.15
- MRK 49.31
About MNTSW Momentus Inc. Warrant
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).